In this study, the clinical data of 126 patients treated with ESD were analyzed, and it was found that tumor size, lymph node metastasis, preoperative serum CEA level, Bacteroides abundance and Enterococcus abundance were the independent risk factors for poor prognosis of ESD treatment. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.